M E M van der Noordaa1, F H van Duijnhoven1, M E Straver2, E J Groen3, M Stokkel4, C E Loo5, P H M Elkhuizen6, N S Russell6, M T F D Vrancken Peeters7. 1. Department of Surgical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. 2. Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands. 3. Department of Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. 4. Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. 5. Department of Radiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. 6. Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. 7. Department of Surgical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. m.vrancken@nki.nl.
Abstract
BACKGROUND: Axillary lymph node dissection (ALND) is frequently performed for node-positive (cN+) breast cancer patients. Combining positron emission tomography/computed tomography (PET/CT) before-NST and the MARI (marking axillary lymph nodes with radioactive iodine seeds) procedure after neoadjuvant systemic therapy (NST) has the potential for avoiding unnecessary ALNDs. This report presents the results from implementation of this strategy. METHODS: All breast cancer patients treated with NST at the Netherlands Cancer Institute who underwent a PET/CT and the MARI procedure from July 2014 to July 2017 were included in the study. All the patients underwent tailored axillary treatment according to a protocol based on the combined results of PET/CT before NST and the MARI procedure after NST. With this protocol, patients showing one to three FDG-avid axillary lymph nodes (ALNs) on PET/CT (cN<4) and a tumor-negative MARI node receive no further axillary treatment. All cN (<4) patients with a tumor-positive MARI node receive locoregional radiotherapy, as well as patients with four or more FDG-avid ALNs [cN(4+)] and a tumor-negative MARI node after NST. An ALND is performed only for cN(4+) patients with a tumor-positive MARI node. RESULTS: The data of 159 patients who received a PET/CT before NST and a MARI procedure after NST were analyzed. Of these patients, 110 had one to three FDG-avid ALNs and 49 patients showed four or more FDG-avid ALNs on PET/CT before NST. For 130 patients (82%), ALND was omitted. Locoregional radiotherapy was administered to 91 patients (57%), and 39 patients (25%) received no further axillary treatment. CONCLUSION: Combining pre-NST axillary staging with PET/CT and post-NST staging with the MARI procedure resulted in an 82% reduction of ALNDs for cN + breast cancer patients.
BACKGROUND: Axillary lymph node dissection (ALND) is frequently performed for node-positive (cN+) breast cancerpatients. Combining positron emission tomography/computed tomography (PET/CT) before-NST and the MARI (marking axillary lymph nodes with radioactive iodine seeds) procedure after neoadjuvant systemic therapy (NST) has the potential for avoiding unnecessary ALNDs. This report presents the results from implementation of this strategy. METHODS: All breast cancerpatients treated with NST at the Netherlands Cancer Institute who underwent a PET/CT and the MARI procedure from July 2014 to July 2017 were included in the study. All the patients underwent tailored axillary treatment according to a protocol based on the combined results of PET/CT before NST and the MARI procedure after NST. With this protocol, patients showing one to three FDG-avid axillary lymph nodes (ALNs) on PET/CT (cN<4) and a tumor-negative MARI node receive no further axillary treatment. All cN (<4) patients with a tumor-positive MARI node receive locoregional radiotherapy, as well as patients with four or more FDG-avid ALNs [cN(4+)] and a tumor-negative MARI node after NST. An ALND is performed only for cN(4+) patients with a tumor-positive MARI node. RESULTS: The data of 159 patients who received a PET/CT before NST and a MARI procedure after NST were analyzed. Of these patients, 110 had one to three FDG-avid ALNs and 49 patients showed four or more FDG-avid ALNs on PET/CT before NST. For 130 patients (82%), ALND was omitted. Locoregional radiotherapy was administered to 91 patients (57%), and 39 patients (25%) received no further axillary treatment. CONCLUSION: Combining pre-NST axillary staging with PET/CT and post-NST staging with the MARI procedure resulted in an 82% reduction of ALNDs for cN + breast cancerpatients.
Authors: Marieke E M van der Noordaa; Ileana Ioan; Emiel J Rutgers; Erik van Werkhoven; Claudette E Loo; Rosie Voorthuis; Jelle Wesseling; Japke van Urk; Terry Wiersma; Vincent Dezentje; Marie-Jeanne T F D Vrancken Peeters; Frederieke H van Duijnhoven Journal: Ann Surg Oncol Date: 2021-05-12 Impact factor: 5.344
Authors: Sabine R de Wild; Janine M Simons; Marie-Jeanne T F D Vrancken Peeters; Marjolein L Smidt; Linetta B Koppert Journal: Breast Care (Basel) Date: 2021-08-17 Impact factor: 2.860
Authors: Ariane A van Loevezijn; Marieke E M van der Noordaa; Erik D van Werkhoven; Claudette E Loo; Gonneke A O Winter-Warnars; Terry Wiersma; Koen K van de Vijver; Emilie J Groen; Charlotte F J M Blanken-Peeters; Bas J G L Zonneveld; Gabe S Sonke; Frederieke H van Duijnhoven; Marie-Jeanne T F D Vrancken Peeters Journal: Ann Surg Oncol Date: 2020-12-02 Impact factor: 5.344
Authors: Janine M Simons; Thiemo J A van Nijnatten; Carmen C van der Pol; Ernest J T Luiten; Linetta B Koppert; Marjolein L Smidt Journal: Ann Surg Date: 2019-03 Impact factor: 12.969
Authors: B Schermers; V Franke; E A Rozeman; B A van de Wiel; A Bruining; M W Wouters; W J van Houdt; B Ten Haken; S H Muller; C Bierman; T J M Ruers; C U Blank; A C J van Akkooi Journal: Br J Surg Date: 2019-03-18 Impact factor: 6.939
Authors: J M Simons; M L M A van Pelt; A W K S Marinelli; M E Straver; A M Zeillemaker; L M Pereira Arias-Bouda; T J A van Nijnatten; L B Koppert; K K Hunt; M L Smidt; E J T Luiten; C C van der Pol Journal: Br J Surg Date: 2019-10-08 Impact factor: 6.939
Authors: Daan Hellingman; Maarten L Donswijk; Gonneke A O Winter-Warnars; Petra de Koekkoek-Doll; Marilyn Pinas; Yvonne Budde-van Namen; Johan Westerga; Marie-Jeanne T F D Vrancken Peeters; Nikola Kimmings; Marcel P M Stokkel Journal: EJNMMI Res Date: 2019-10-24 Impact factor: 3.138